Ritholtz Wealth Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $309K | Buy |
1,075
+250
| +30% | +$71.8K | 0.01% | 783 |
|
|
2025
Q1 | $254K | Hold |
825
| – | – | 0.01% | 792 |
|
|
2024
Q4 | $291K | Sell |
825
-14
| -2% | -$4.94K | 0.01% | 716 |
|
|
2024
Q3 | $301K | Buy |
839
+105
| +14% | +$37.6K | 0.01% | 698 |
|
|
2024
Q2 | $234K | Buy |
+734
| New | +$234K | 0.01% | 722 |
|
|
2023
Q1 | – | Sell |
-1,026
| Closed | -$285K | – | 672 |
|
|
2022
Q4 | $285K | Sell |
1,026
-267
| -21% | -$74.3K | 0.02% | 465 |
|
|
2022
Q3 | $271K | Buy |
1,293
+120
| +10% | +$25.2K | 0.01% | 574 |
|
|
2022
Q2 | $276K | Sell |
1,173
-250
| -18% | -$58.8K | 0.02% | 429 |
|
|
2022
Q1 | $255K | Sell |
1,423
-1,237
| -47% | -$222K | 0.02% | 447 |
|
|
2021
Q4 | $575K | Buy |
2,660
+67
| +3% | +$14.5K | 0.04% | 270 |
|
|
2021
Q3 | $479K | Buy |
2,593
+517
| +25% | +$95.5K | 0.03% | 279 |
|
|
2021
Q2 | $372K | Buy |
2,076
+508
| +32% | +$91K | 0.03% | 322 |
|
|
2021
Q1 | $262K | Buy |
+1,568
| New | +$262K | 0.02% | 345 |
|